Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
Go back to Telix and RefleXion Expand Partnership for Prostate Cancer Treatment| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 7.52 +0.39 (5.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.13 | 52 Week High | $2.18 | |||
| Open | $7.32 | 52 Week Low | $0.30 | |||
| Day High | $7.63 | P/E | N/A | |||
| Day Low | $7.30 | EPS | $-3.32 | |||
| Volume | 515,987 | |||||
